118 related articles for article (PubMed ID: 38700299)
1. Sputum Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Asthma-COPD Overlap.
Babu A; Narayanswamy H; Baburao A
J Assoc Physicians India; 2023 Sep; 71(9):34-38. PubMed ID: 38700299
[TBL] [Abstract][Full Text] [Related]
2. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap.
Jo YS; Kwon SO; Kim J; Kim WJ
J Thorac Dis; 2018 Aug; 10(8):5047-5056. PubMed ID: 30233879
[TBL] [Abstract][Full Text] [Related]
4. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
Wang J; Lv H; Luo Z; Mou S; Liu J; Liu C; Deng S; Jiang Y; Lin J; Wu C; Liu X; He J; Jiang D
Respir Res; 2018 Mar; 19(1):47. PubMed ID: 29580282
[TBL] [Abstract][Full Text] [Related]
5. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
[TBL] [Abstract][Full Text] [Related]
7. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
Iwamoto H; Gao J; Koskela J; Kinnula V; Kobayashi H; Laitinen T; Mazur W
Eur Respir J; 2014 Feb; 43(2):421-9. PubMed ID: 23794464
[TBL] [Abstract][Full Text] [Related]
8. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
10. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
Li M; Yang T; He R; Li A; Dang W; Liu X; Chen M
Int J Chron Obstruct Pulmon Dis; 2020; 15():3025-3037. PubMed ID: 33244228
[TBL] [Abstract][Full Text] [Related]
11. Differential DAMP release was observed in the sputum of COPD, asthma and asthma-COPD overlap (ACO) patients.
Huang X; Tan X; Liang Y; Hou C; Qu D; Li M; Huang Q
Sci Rep; 2019 Dec; 9(1):19241. PubMed ID: 31848359
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care.
Izbicki G; Teo V; Liang J; Russell GM; Holland AE; Zwar NA; Bonevski B; Mahal A; Eustace P; Paul E; Phillips K; Wilson S; George J; Abramson MJ
Int J Chron Obstruct Pulmon Dis; 2019; 14():2745-2752. PubMed ID: 31819406
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
[TBL] [Abstract][Full Text] [Related]
14. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
Hou C; Zhao H; Liu L; Li W; Zhou X; Lv Y; Shen X; Liang Z; Cai S; Zou F
Mol Med; 2011; 17(7-8):807-15. PubMed ID: 21380479
[TBL] [Abstract][Full Text] [Related]
15. Use of clinical characteristics to predict spirometric classification of obstructive lung disease.
Pascoe SJ; Wu W; Collison KA; Nelsen LM; Wurst KE; Lee LA
Int J Chron Obstruct Pulmon Dis; 2018; 13():889-902. PubMed ID: 29559773
[TBL] [Abstract][Full Text] [Related]
16. Current situation of asthma-COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study.
Kang J; Zheng J; Cai B; Wen F; Yao W; Zhang X; Chen Y; Wang G; Li W; Cao J
Ther Adv Respir Dis; 2020; 14():1753466620961699. PubMed ID: 33103591
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Blood Biomarkers in Patients with Chronic Obstructive Pulmonary Disease (COPD) and with Asthma-COPD Overlap (ACO).
Gava G; Núñez A; Esquinas C; Sarasate M; Loeb E; Pirina P; Miravitlles M; Barrecheguren M
COPD; 2020 Jun; 17(3):306-310. PubMed ID: 32380914
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
Pérez de Llano L; Cosío BG; Miravitlles M; Plaza V;
Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):198-204. PubMed ID: 29229474
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population.
Guerriero M; Caminati M; Viegi G; Senna G; Pomari C
J Asthma; 2019 Jan; 56(1):27-33. PubMed ID: 29420087
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study.
Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3411-3417. PubMed ID: 30425470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
